TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: AUC of intact GLP-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cognitive Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants needed to uncover use errors
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants With PASI-75
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Clinical improvement after cell transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cognitive Assessment Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prevalence of SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Microorganisms reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Changes in base acrylic resin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contact sensitization potential measured by Treatment emergent
Endpoint domain: Adverse events/effects
Primary endpoint: Contact sensitization potential measured by Reaction Grade
Endpoint domain: Adverse events/effects
Primary endpoint: Contact sensitization potential measured by Investigator assessment of irritation and sensitization
Endpoint domain: Adverse events/effects
Primary endpoint: Cmax of AR-C124910XX
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-∞ of Ticagrelor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-∞ of AR-C124910XX
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: taste preference of eltrombopag
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HbA1c (Glycosylated Haemoglobin A1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Patients With Resolved Skin Problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Follow-Up Visits to Any Provider for the Same Problem
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Metabolic Availability of Lysine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 24-hours Systolic Blood Pressure at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 24-hours Diastolic Blood Pressure at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants With a Dipper Circadian Blood Pressure Pattern at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: muscle cross sectional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle fascicle length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of progression to SCC
Endpoint domain: Mortality/survival
Primary endpoint: Help-seeking behavior for eating and body image issues
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: VAS (Visual Analog Scale score) for soreness or pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FI (Fatigue Index)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Success rate of mandibular overdentures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax for bococizumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCinf for bococizumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Percent Agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in auditory processing skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma levels of sPD-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPAP adherence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction in Pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Serum teicoplanin trough concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: User Burden Scale
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Seated systolic blood pressure 1-hr post drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of clinical remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect of nutrition training
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Conventional Medicine Attitudes Scale (CACMAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent of Baseline Level of Salivary Cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain Relief With Visual Analog (VAS) Pain Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Quality of Life as Measured by the World Health Organization Quality of Life (WHOQOL-BREF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Spinal Cord Independence Measure (SCIM)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Median Volume of Mediastinal Fluid Collected
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: steady-state pharmacokinetics (PK) of telaprevir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrauterine/fetal growth restriction or perinatal death
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of Postoperative Headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Family Adaptability and Cohesion Evaluation Scales for adolescents (FACES III)
Endpoint domain: Life impact
Endpoint subdomain: Family functioning
Primary endpoint: Family Adaptability and Cohesion Evaluation Scales for parents (FACES III)
Endpoint domain: Life impact
Endpoint subdomain: Family functioning
Primary endpoint: The Coparenting Inventory for Parents and Adolescents (CI-PA)
Endpoint domain: Life impact
Endpoint subdomain: Family functioning
Primary endpoint: Family Attitude Scale, l'échelle d'attitude familiale (FAS-30)
Endpoint domain: Life impact
Endpoint subdomain: Family functioning
Primary endpoint: Child Behavior Check List (CBCL)
Endpoint domain: Life impact
Endpoint subdomain: Child behavior
Primary endpoint: Radiological Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ5D Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: non-cyclical breast pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Resorbed CME in OCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resorbed CME in clinical examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to disappearance of acute diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Hemoglobin A1C Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HDL-C Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Zeno Walkway Analysis of Gait Speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30 Second Sit to Stand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single Leg Stance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attentional bias measured by fixation time on faces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reward sensitivity measured by amplitude of saccade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive control measured by amplitude of antisaccade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in number and depth of micro scotoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Saliva test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SAPASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Subjects With Seroprotective Immune Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Diameter change of Dilapan-S
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Perceived Pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reconstructed bowel continuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: History of Fall
Endpoint domain: Adverse events/effects
Primary endpoint: Change in 6 min. walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional shoulder scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: inflammation and metabolic status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Assessment of Fatty liver
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: self-report measurement of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Experienced Adverse Events Grade 3 or Higher
Endpoint domain: Adverse events/effects
Primary endpoint: Prostate-Specific Antigen (PSA) Complete Response (CR) Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Gut Microbiota Community Composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Precision of intraoral scanner compared with photogrammetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IVC Filter Penetration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Quantification of disease related white blood cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Contraception choice
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: suicidal act frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Temporal summation (TS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of levonadifloxacin in epithelial lining fluid and alveolar macrophage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of temporomandibular joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal Fluency Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: % of Total Nucleated Cell (TNC) yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: % of CD34 + cells yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: % of CFU-GM yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Geometric Mean Titers of Hemaglutination Inhibition (HI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events occurring over the immediate 30-minute post vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: postoperative cure score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of Participants Who Experienced a Complete Response During the Delayed Phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Who Discontinued Study Drug Due to an Adverse Event
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Level of concordance in sentinel node localization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in postprandial Gut peptide responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in weight, fat mass and lean body mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incident and severity of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Participants Opioid-Free After Gynecologic Surgery for 48 Hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intra-class correlation coefficient between two successive NIRS measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cronbach alpha coefficient between NIRS and TcPO2 measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIRS values at the first consultation and the time to complete healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in total Y-BOCS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aggregated diagnostic concordance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Grades 3-5 Treatment Related Immune Related Adverse Events (irAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Objective Response Rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 7 point SMBG (self monitoring of blood glucose)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Self Report of Smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CO (Carbon Monoxide) Breathalyzer Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Cotinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite Score of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in LogMAR Best Corrected Visual Acuity (BCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PANSS score changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Behavioral Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alpha Band Power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of wound preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary protein:urinary creatinine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Inactive urinary sediment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cmax of BAY1902607
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of BAY1902607
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in bone density buccal to the implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in bone width gain at the undercut area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Refractive error progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: base excess
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Knee pain while walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in independence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in physiological fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilation Defect Percent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in average and worst pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Ra
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Symptom severity and functional status score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Assessment Of Joint Position Sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Assessment of Joint Passive Motion Sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Assessment of Vibration Sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Assesment of Deep Pain Sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Assessment of Two-point Discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Assessment of Graphesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Patient satisfaction with MTM and PGx
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in clinical biomarkers associated with drug therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of recommended drug selection/dosing adjustments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of subjects enrolled and completing the app modules
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to fistula maturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Difference in number of fistula intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Severe invasive GAS disease
Endpoint domain: Mortality/survival
Primary endpoint: Change in inflammatory biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total Severity Score (TSS) Percent Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major cardiovascular event (MACE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Glasgow Outcome Scale-Extended (GOSE)≤4 at 6 Months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of Subjects With Sustained Treatment Transition
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Absolute Change From Baseline Over Time in Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Subjects With Treatment-emergent Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: variation of blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: variation of glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: End-expiratory lung volume change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of Subjects With Non-ulcerative Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma GSK1605786 parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ∆PP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ∆POP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PVI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in Total Cholesterol at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Geometric Mean Titre (GMT) of Varicella Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: VIO System Imaging Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VIO System Image Quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global gastrointestinal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Self-control capacity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mindfulness attention awareness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean 24-hour glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean 24-hour insulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Function assessed with the Constant-Murley-Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Function assessed with the Subjective Shoulder Value
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Tolerability and Safety of the Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Vessel wall pathology findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes